These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3296610)

  • 1. [Indications for the use of lamprene in the treatment of leprosy].
    Browne SG
    Acta Leprol; 1986; 4(4):409-11. PubMed ID: 3296610
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy.
    Hogerzeil LM
    Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamprene (clofazimine) and its side effects.
    Salafia A; Kharkar RD
    Indian J Lepr; 1987; 59(3):313-4. PubMed ID: 3440850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofazimine in pregnancy complicated by leprosy.
    Farb H; West DP; Pedvis-Leftick A
    Obstet Gynecol; 1982 Jan; 59(1):122-3. PubMed ID: 7078842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamprene (clofazimine) in leprosy. Basic information.
    Yawalkar SJ; Vischer W
    Lepr Rev; 1979 Jun; 50(2):135-44. PubMed ID: 396428
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of clofazimine (Lamprene) in the management of reactive phases of leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):105-9. PubMed ID: 1100948
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of long-term steroid therapy on patients treated with clofazimine (Lamprene).
    Hogerzeil LM; Prabhudas N
    Lepr Rev; 1975 Jun; 46(2 Suppl):111-5. PubMed ID: 1100949
    [No Abstract]   [Full Text] [Related]  

  • 10. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of treatment with clofazimine (Lamprene: B663).
    Jopling WH
    Lepr Rev; 1976 Mar; 47(1):1-3. PubMed ID: 1263731
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of clofazimine in leprosy patients.
    Feng PC; Fenselau CC; Jacobson RR
    Drug Metab Dispos; 1981; 9(6):521-4. PubMed ID: 6120809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine for leprosy and Mycobacterium avium complex infections.
    Med Lett Drugs Ther; 1987 Aug; 29(746):77-8. PubMed ID: 3614089
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of leprosy--newer concepts.
    Kaur S; Sharma VK; Kumar B
    Indian J Lepr; 1984; 56(2):307-12. PubMed ID: 6548500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lamprène. New therapeutic indications (excluding leprosy)].
    Beurey J; Weber M; Chaulieu Y
    LARC Med; 1982 Jan; 2(1):48-50, 53, 55. PubMed ID: 6219260
    [No Abstract]   [Full Text] [Related]  

  • 17. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 20. Does clofazimine have any value in the management of reversal reaction?
    Ross WF
    Lepr Rev; 1980 Mar; 51(1):92-3. PubMed ID: 7464423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.